Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK

INTRODUCTION: Treatment of giant cell arteritis (GCA) involves immediate initiation of high-dose glucocorticoid therapy with slow tapering of the dose over many months. Chronic exposure to glucocorticoids is associated with serious comorbidities. The objective of this analysis was to determine the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Gale, Sara, Wilson, Jessica C., Chia, Jenny, Trinh, Huong, Tuckwell, Katie, Collinson, Neil, Dimonaco, Sophie, Jick, Susan, Meier, Christoph, Mohan, Shalini V., Sarsour, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251855/
https://www.ncbi.nlm.nih.gov/pubmed/29752705
http://dx.doi.org/10.1007/s40744-018-0112-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251855/
https://www.ncbi.nlm.nih.gov/pubmed/29752705
http://dx.doi.org/10.1007/s40744-018-0112-8

Ejemplares similares